Geneos Wealth Management’s Akoustis Technologies Inc AKTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-700
Closed -$581 2235
2023
Q4
$581 Hold
700
﹤0.01% 2080
2023
Q3
$525 Hold
700
﹤0.01% 2089
2023
Q2
$2.23K Hold
700
﹤0.01% 1912
2023
Q1
$2.16K Buy
+700
New +$2.44K ﹤0.01% 1891

Other funds holding AKTS

Geneos Wealth Management's AKTS Position: Q1 2024 in Review

Geneos Wealth Management sold out of Akoustis Technologies Inc (AKTS) in Q1 2024, closing a stake of 700 shares — an estimated $581 sold.

Geneos Wealth Management first reported a position in AKTS in Q1 2023 and held it in 4 quarters. The position peaked at $2.23K in Q2 2023. 118 funds tracked by Wall St. Rank hold AKTS as of Q1 2024.

  • Geneos Wealth Management reported no remaining Akoustis Technologies Inc position as of Q1 2024 after selling out during the quarter.
  • Geneos Wealth Management sold 700 Akoustis Technologies Inc shares in Q1 2024, an estimated $581.
  • Geneos Wealth Management first reported a position in Akoustis Technologies Inc in Q1 2023 and held it in 4 quarters.
  • Geneos Wealth Management's Akoustis Technologies Inc position peaked at $2.23K in Q2 2023.
  • 118 funds tracked by Wall St. Rank held Akoustis Technologies Inc as of Q1 2024.

Based on Geneos Wealth Management's 13F filing for Q1 2024, filed 3 May 2024.